The ESG software group Diginex has wasted no time putting its acquisition machine to work. Since listing on the Nasdaq in January 2025, the company has deployed more than $100 million on three separate takeovers, and it is now reshaping its executive ranks to convert those purchases into measurable top-line growth. The appointment of Archana Kotecha as Chief Impact Officer — effective immediately — marks the latest step in that integration push, as the group eyes a rapidly expanding market for supply-chain due diligence.
Kotecha previously founded The Remedy Project, a human-rights consultancy that Diginex acquired in January for $7.6 million. In her new role, the lawyer will be responsible for weaving the company’s sustainability and compliance capabilities into unified product offerings. She brings deep ties to policymakers: Kotecha advises the European Commission and several United Nations agencies on supply-chain matters, and from June she will lead a masterclass series for procurement officers focused on data-driven risk management that goes beyond simple regulatory box-ticking.
The timing is no coincidence. Regulatory scrutiny and investor pressure have pushed the global market for supply-chain due diligence to $3.8 billion last year, and industry forecasts expect it to more than double to $9.6 billion by 2034. Diginex, which operates debt-free, has been using the cash cushion from its IPO — including roughly $25 million in fresh equity — to snap up companies that fill gaps in its software and data infrastructure stack.
Should investors sell immediately? Or is it worth buying Diginex?
The acquisition tally includes:
- Matter DK ApS (October 2025) – $13 million
- The Remedy Project (January 2026) – $7.6 million
- Plan A (February 2026) – $80 million
But the biggest bet of all remains unfinished. Diginex announced on May 14 that the long-stop date for its proposed all-stock acquisition of marketing-technology firm Resulticks — valued at roughly $1.5 billion — has been pushed back to May 29. The two companies already have a reseller agreement expected to generate $40 million in revenue over four years, and the deal is central to the group’s narrative of becoming a heavyweight in AI-powered data analytics and enterprise software. Every additional day of delay, however, adds to the pressure on management to close the transaction and prove the strategy can deliver.
That pressure is most visible in Diginex’s stock price, which has fallen off a cliff. Founder Miles Pelham personally invested $25.4 million into his own company’s shares at an average price of $5.69. With the stock now trading around $1.20, that stake has lost more than three-quarters of its value. Year-to-date, the decline totals roughly 96.4%. The market, it seems, is focusing less on the pipeline of acquisitions and more on execution risk — especially with the Resulticks deadline looming. If the deal closes, Diginex will have a concrete validation point for its expansion thesis. Until then, the clock is ticking.
Ad
Diginex Stock: Buy or Sell?! New Diginex Analysis from May 14 delivers the answer:
The latest Diginex figures speak for themselves: Urgent action needed for Diginex investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from May 14.
Diginex: Buy or sell? Read more here...
